Lotte is a Scientific Vice President in Global Research at Novo Nordisk in Denmark. She is a chemist by training, has a doctoral degree in scientific medicine and has worked for Novo Nordisk for 30 years. She is a recognised expert of GLP-1 based drug discovery and mechanism of action studies in diabetes, obesity and toxicology. Her research focuses on drug discovery, receptor expression, molecular pharmacology, in vivo pharmacology, mechanistic toxicology and mechanism of action of drugs in obesity and diabetes, and has resulted in app. 70 peer-reviewed original papers.